Previous close | 0.5109 |
Open | 0.5250 |
Bid | 0.5100 x 1000 |
Ask | 0.5199 x 4000 |
Day's range | 0.5000 - 0.5210 |
52-week range | 0.2500 - 0.9100 |
Volume | |
Avg. volume | 1,010,373 |
Market cap | 34.736M |
Beta (5Y monthly) | 1.77 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.2600 |
Earnings date | 10 Jul 2024 - 15 Jul 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 3.25 |
POTOMAC, Md., April 16, 2024--IGC-AD1’s Interim Phase 2 Data Show a Reduction in Alzheimer’s Agitation at Week Two.
POTOMAC, Md., April 09, 2024--IGC Pharma Adds Advisor in Artificial Intelligence
POTOMAC, Md., March 26, 2024--IGC Pharma Announces $3 Million Unregistered Private Placement of its Common Stock